Combined PD-1 and CCR5 Inhibition for the Treatment of Refractory Microsatellite Stable mCRC
收藏NIAID Data Ecosystem2026-03-10 收录
官方服务：
资源简介：
This is a monocentric, single arm, prospective, open-label trial of a combination treatment consisting of pembrolizumab and maraviroc in previously treated subjects who have refractory microsatellite stable (MSS) metastatic colorectal cancer (mCRC).
创建时间：
2018-04-15
